Diffusion Pharmaceuticals Inc. Made Big Gain
Wed 11 Dec 19 at 05:30 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) rocketted at $0.57, representing a gain of 31.4%. The stock got featured on our News Catalysts scanner on Wed 11 Dec 19 at 12:39 PM in the 'BIOTECH' category. From Tue 19 Nov 19, the stock recorded 50.00% Up Days and 26.67% Green Days
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- CTI Industries Corporation (CTIB:NASDAQ), 150.81%
- DPW Holdings, Inc. (DPW:NYSEMKT), 82.39%
- Forward Pharma A/S (FWP:NASDAQ), 69.91%
- Camber Energy, Inc. (CEI:NYSEMKT), 69.42%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 40.72%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 37.98%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 31.4%
- Immunic, Inc. (IMUX:NASDAQ), 24.62%
- Centogene N.V. (CNTG:NASDAQ), 23.76%
- Neon Therapeutics, Inc. (NTGN:NASDAQ), 23.64%